DPDaria V. Podchinenova

Daria V. Podchinenova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daria V. Podchinenova has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • ASSESSMENT OF THE RELATIONSHIPS OF ASPROSIN WITH CHANGES IN THE CARDIOVASCULAR AND RESPIRATORY SYSTEMS IN CHILDREN AND ADOLESCENTS AGED 12–17 YEARS WITH OBESITY AND NORMAL BODY WEIGHT: A CROSS-SECTIONAL COMPARATIVE STUDY

    by Iu.G. Samoilova, D.A. Kudlay, D.V. Podchinenova, O.A. Oleynik, I.YU. Yakimovich, D.A. Korolevskiy

    Obesity in children and adolescents is accompanied by dysfunction of adipose tissue as an endocrine organ secreting biologically active molecules, namely adipokines. Asprosin is a recently discovered adipokine involved in the regulation of appetite, glucose homeostasis and lipid metabolism. Its role in the pathogenesis of cardiorespiratory disorders and changes in energy metabolism in childhood obesity is insufficiently studied. Objective: To assess the relationships of asprosin levels with cardiovascular and respiratory parameters during cardiorespiratory testing, as well as with parameters of indirect calorimetry performed at rest in children and adolescents with obesity. Materials and Methods: A single-center cross-sectional study was conducted. The enrollment period was September 2024 – January 2026. Correlations of asprosin with cardiorespiratory parameters and parameters of indirect calorimetry were assessed. Anthropometry, bioimpedance analysis, bicycle ergometry with gas analysis were carried out to assess cardiorespiratory parameters and parameters of indirect calorimetry, and enzyme-linked immunosorbent assay of blood serum was performed to determine asprosin concentration. Pearson correlation analysis was performed. Results: The study included 175 individuals aged 12–17 years: 88 obese adolescents, including 47 boys and 41 girls, and 87 healthy peers with normal body weight, including 39 boys and 48 girls. When processing the results, early termination of exercise testing in patients of the main group was taken into account. In obese adolescents, statistically significant positive correlations of asprosin with anthropometric parameters (BMI: r=0.79; body weight: r=0.76; fat mass: r=0.76; p<0.001), metabolic disorders (glucose: r=0.86; triglycerides: r=0.88; LDL: r=0.89; ALT: r=0.91; p<0.001) and negative correlations with HDL (r=–0.88; p<0.001) were found. Inverse associations of asprosin with measures of physical performance (maximum load power: r=Pearson correlation analysis was performed. Results: The study included 175 individuals aged 120.25; MET: r=–0.17; p<0.046) and direct associations with ventilatory oxygen equivalent (EqO2: r=0.32; p<0.001) were detected. Analysis of indirect calorimetry parameters revealed positive correlations of asprosin with absolute oxygen uptake (VO2: r=0.42; p<0.001) and carbon dioxide production (VCO2: r=0.41; p<0.001), as well as with resting energy expenditure (REE: r=0.44; p<0.001). At the same time, a negative correlation with the respiratory exchange ratio (RER: r=Pearson correlation analysis was performed. Results: The study included 175 individuals aged 120.39; p<0.001) was found, indicating predominant fat oxidation. Conclusion: Asprosin is closely associated with key components of metabolic syndrome and cardiorespiratory parameters in obese adolescents. The identified correlations with indirect calorimetry parameters suggest its involvement in the regulation of energy metabolism and substrate oxidation. The obtained data suggest asprosin as a potential biomarker of cardiometabolic risk and a target for therapeutic interventions in pediatric practice.

  • Assessment of the parameters of the fatty acid spectrum of blood serum in relation to hormonal status in obese adolescents

    by I. E. Esimova, O. V. Voronkova, Iu. G. Samoilova, D. V. Podchinenova

    Rationale . The development and implementation of new high-tech mass spectrometric diagnostic methods into laboratory practice has determined the possibility of a global analysis of the human lipidome, in particular, for a detailed study of its fatty acid component and assessment of the role of individual free fatty acids (FFA) in the pathogenesis of obesity and associated diseases. Objective . To identify the features of changes in the parameters of the fatty acid spectrum of blood serum and establish their relationship to hormonal status indicators in adolescents with obesity. Materials and methods . A total of 27 adolescents aged 10–18 years with obesity (SDS BMI 2.0-3.9) were examined. The control group consisted of 27 adolescents with normal weight with comparable characteristics by gender and age. SDS BMI was calculated using the WHO Anthroplus calculator. The concentration of hormones and peptides in the blood serum was measured by ELISA. The mobile fatty acid pool of blood serum was assessed by chromatography-mass spectrometry on an Agilent 7000B detector. Results . In adolescents with obesity of 1–3 degrees, elevated levels of insulin and C-peptide, decreased concentration of GLP-2 and fatty acid imbalance (decreased proportion of GLA, DGLA, DPA, DHA, AA and increased content of ALA, OA, POA, BA, MA, PA, MAA), as well as a low risk index for the development of a subintimal inflammatory reaction are recorded in the blood. In the group with obesity, direct and negative correlations were established between the content of individual hormones and fatty acids, which were absent between the corresponding parameters in the group of healthy individuals. Conclusion . The established endocrine-metabolic changes in adolescents with obesity are pathogenetic factors of a complex of compensatory-adaptive reactions accompanying low-intensity inflammation.

  • Open Access

    Clinical and Metabolic Profile and Cognitive Functions in Children and Adolescents with Carbohydrate Metabolism Disorders Depending on Body Weight

    by Yuliya G. Samoylova, Mariya V. Matveeva, Tatyana A. Filippova, Darya V. Podchinenova, Vera E. Yun, Darya E. Galyukova, Marina V. Koshmeleva, Самойлова Юлия Геннадьевна, Галюкова Дарья Евгеньевна

    INTRODUCTION: Hyperglycemia causes glucotoxicity of neurons via different mechanisms, and, in combination with obesity, is a strong predictor of cognitive dysfunction. Free fatty acids and circulating cytokines cross the blood-brain barrier leading to neuroinflammation and proliferation of microglia. These alterations can be detected using neuroimaging methods. Thus, evaluation of cognitive functions and glycemic profile seems relevant in children with disorders of carbohydrate metabolism and different weights. AIM: To analyze clinical and metabolic profile and cognitive functions in children and adolescents with carbohydrate metabolism disorders depending on body weight. MATERIALS AND METHODS: A prospective, open, controlled study was conducted in 2022–2023. The study included 53 children aged from 7 to 18 years with carbohydrate metabolism disorders with duration of the disease of 1 to 7 years: group 1 — children with excessive body weight or obesity (n=33) and group 2 (n=20) — children with normal body weight. The work included evaluation of anthropometric parameters, carbohydrate metabolism disorders (glycemia and its variability, determination of glycated hemoglobin, immunoreactive insulin, and C-peptide), lipid spectrum, verification of non-alcoholic fatty liver disease, and testing using children’s version of Wechsler questionnaire. RESULTS: Children with carbohydrate metabolism disorders and overweight or obesity more often had relatives with overweight (p=0.04), or diabetes mellitus (p=0.03) and were more often diagnosed with lipidemia (p=0.048) and fatty hepatosis (p=0.031). Children with carbohydrate metabolism disorders, both normal and overweight, showed statistically significant differences in the immunoreactive insulin index: among boys (p=0.030, p=0.001) and girls (р=0.020, р=0.002). Glycemia before bedtime and the time of glycemia above the target range were higher in overweight children (p=0.029, p=0.002). In Wechsler test, children with overweight or obesity and normal body weight children differed in the following parameters: vocabulary (speech function), letter-digit test, Kohs Block Design Test (constructional-spatial praxis; p=0.043, p=0.008 and p=0.005 respectively). CONCLUSIONS: Children with carbohydrate metabolism disorders in combination with excessive body weight and obesity are characterized by impairment of some cognitive functions associated with asymptomatic glycemic variability.


  • Features of the mobile pool of fatty acids (lipoproteins and free fatty acids) in adolescents with different body weights

    by Yulia G. Samoilova, Oksana A. Oleynik, Daria V. Podchinenova, Maria V. Matveeva, Irina N. Vorozhtsova, Margarita A. Kovarenko, Lyudmila Shuliko, Tamara D. Vachadze

    Background — Studying the lipidome and, in particular, the mobile pool of fatty acids (FA) can provide more detailed information about the development and maintenance of excess body fat, which makes this scientific direction promising. The goal of this study was to investigate the characteristics of the mobile pool of FA, including membrane indices in adolescents with different body weights. Methods — The study included 75 adolescents aged 10 to 17 years. The main group (n=45) included adolescents with Grade 1 and Grade 2 alimentary obesity. The control group comprised 30 healthy adolescents. The control and main groups were divided into subgroups based on gender. Anthropometric assessment included measuring height and body weight. The mobile pool of FA (lipoproteins and free fatty acids, FFA) in the blood serum was analyzed on an Agilent 7000B chromatography mass spectrometry device. Results — Among boys, a number of indices demonstrated statistically significant changes, e.g., whole blood ω-3 index (1.335 [1.230; 1.540] % of FA) and erythrocyte membrane ω-3 index (1.620 [1.520; 1.813] % of FA). The ω-6/ω-3 FA ratio in the presence of obesity (13.310 [11.400; 16.705] % of FA) exceeded the upper limit of the laboratory reference range (2.90-13.06% of FA) in boys. The subintimal inflammatory response risk index was elevated in both groups, but was significantly higher among adolescents with normal body weight (51.320 [38.368; 57.260] % of FA and 81.450 [63.120; 210.860] % of FA, respectively). The polyunsaturated/saturated FA index demonstrated levels of 0.400 [0.375; 0.558] % of FA and 0.740 [0.630; 0.990] % of FA in the main and control groups, respectively. Among girls, a number of indices demonstrated statistically significant changes: e.g., ω-3 FA (% of saturated FA) in the obese group showed a level of 1.680 [1.365; 1.910] % of FA, ω-6 FA (% of saturated FA) also demonstrated a reduction in the presence of obesity (21.050 [19.130; 23.100] % of FA). Levels of polyunsaturated FA (% of total FA) were lower both vs. the control group and reference values (36.67-47.73% of FA): 22.380 [20.790; 24.990] % of FA and 35.460 [30.290; 42.950] % of FA, respectively. Saturated FA (% of total FA) exceeded the reference threshold (34.09-40.74% of FA) in both study groups: 55.240 [52.470; 56.185] % of FA and 45.900 [38.160; 50.290] % of FA, respectively. The subintimal inflammatory response risk index exhibited an increase both in the obesity group and in the control group (even higher in the latter): 57.090 [49.290; 82.385] % of FA and 136.990 [63.120; 210.860] % of FA, respectively). The polyunsaturated/saturated FA index showed levels of 0.400 [0.390; 0.485] % of FA and 0.810 [0.630; 1.160] % of FA in the main and control groups, respectively. Conclusion — All the indices examined in children (whole blood ω-3 index, erythrocyte membrane ω-3 index, subintimal inflammatory response risk index, cell membrane viscosity, fluidity and permeability index) exhibited statistically significant changes in groups of obese adolescents. These changes were associated not only with increased cardiovascular risk and progression of chronic inflammation, but also with the nature of children’s growth and development.

  • Screen time and obesity in young people

    by Iu.G. Samoilova, M.V. Matveeva, D.V. Podchinenova, O.A. Oleynik, L.M. Shuliko, I.YU. Yakimovich

    The prevalence of obesity among youth contributes to the global burden of chronic diseases over the life course, which is largely attributed to environments that promote excess body weight. This review focuses on the impact of screen time on the health and nutritional hygiene of young people. Excessive screen media use is associated with junk food consumption and snacking, low physical activity, and poor sleep quality. Bidirectional associations of the risk factors for obesity development were verified. The development of current recommendations and effective prevention strategies is crucial for screen time rationing and prevention of adverse consequences in the form of excess body weight. Key words: youth, obesity, nutrition, sleep, physical activity, screen time

  • Open Access

    Features of fatty acid indices in the assessment of metabolic disorders in obese adolescents

    by O. A. Oleynik, Iu. G. Samoilova, M. V. Matveeva, D. V. Podchinenova, L. M. Shuliko, Ю. Г. Самойлова

    Introduction. The population strategy of modern healthcare is aimed at preventing obesity and its complications. The study of the spectrum of fatty acids is a progressive direction of lipidomics in the diagnosis of metabolic disorders.Aim. To evaluate the possibilities of calculated fatty acid indices in determining the risk of metabolic disorders in obese adolescents.Materials and methods. Single-center observational single-stage comparative study. The study sample consisted of 155 adolescents aged 10–15 years. The main group was represented by 101 participants – 45 boys and 56 girls with diagnosed obesity of exogenous constitutional type, 1–2 degrees (SDS BMI +2,0–+3,0 ). The control group included 54 healthy children with -1Results. Significantly lower levels of polyunsaturated fatty acids and higher content of some monounsaturated ω-7 and ω-9 fatty acids, as well as the main representatives of the saturated fatty acid family, were observed in obese adolescents. The values of the ω-3 index, both for whole blood and for erythrocyte membranes, were statistically significantly reduced in the main group. Subintimal inflammatory reaction risk index and PUFA % index/%NLC had high values in boys and girls of both groups. The ω-6/ω-3 index on the background of obesity was increased only in boys. The activity of delta-6-desaturase did not differ statistically significantly between the groups.Conclusions. The presented indices (ω-3 index, risk index of subintimal inflammatory reaction, ω-6/ω-3 index, polyunsaturated/saturated LC index, ω-6 desaturase activity index) require additional study and specification of application conditions, reference values and interpretation rules, especially in the pediatric population.


  • Open Access

    The relationship of free fatty acid levels with cognitive status and neuroimaging characteristics in adolescents with obesity

    by Yu. G. Samoilova, M. V. Matveeva, D. V. Podchinenova, O. A. Oleynik, L. M. Shuliko, M. A. Kovarenko, D. A. Kudlai, Ю. Г. Самойлова

    BACKGROUND: Obesity is a progressive health and economic problem of modern society. Endocrine-metabolic changes in childhood and adolescence have an impact on cognitive status, which is accompanied by changes in the perfusion of gray and white matter of the brain, as well as its architectonics.AIM: Verification of fatty acid (FA) levels in relation to cognitive function and brain neuroimaging data in adolescents with obesity.MATERIALS AND METHODS: The study is a single-center observational one-stage comparative. 60 teenagers aged 10–16 years were selected to participate. The main study group was formed of 34 adolescents with obesity (SDS BMI ≥+2.0), 26 subjects with normal weight made up the control group. The calculation of SDS BMI was performed on the WHO «Anthroplus» calculator. To obtain anthropometric data, a vertical height meter MSK — 233, scales and a soft centimeter tape were used. The levels of free fatty acids in the blood serum were determined by chromatomass spectrometry on the Agilent 7000B detector. For neurocognitive testing, the Montreal Cognitive Function Assessment Scale and the Ray test were used. Contrast-free perfusion magnetic resonance imaging of the brain was performed on a Signa Creator “E” MR tomograph by GE Healthcare, 1.5 Tl, China, by Arterial Spin Labeling. For MR tractography, the GE Sygna Creaton 1.5 Tesla apparatus was used using the method of diffusion imaging with high angular resolution HARDI (High Angular Resolution Diffusion Imaging). Statistical processing of the obtained results was carried out using IBM SPSS Statistics software.RESULTS: According to the results of a comparative analysis, adolescents with obesity were distinguished by an increased content of free LC and a decrease in cognitive functions (p <0.05). A lot of statistically significant correlations of different groups of LC with changes in cognitive characteristics, cerebral blood flow and pathways were also obtained.CONCLUSION: The results obtained confirm the significant role of free fatty acids in the pathogenesis of obesity and indicate the effect of lipotoxicity on morphological changes in the structures of the central nervous system, which can lead to the formation of cognitive disorders.

  • Obesity peculiarities in youth

    by Yu.G. Samoilova, M.V. Matveeva, O.A. Loginova, D.A. Podchinenova, M.A. Kovarenko, T.D. Vachadze

    The problem of obesity is adding relevance. Obesity has become a non-contagious epidemic, affecting an increasing number of people every year, regardless of age, gender, and place of residence. It is associated with a growing risk of life-threatening complications leading to disability. Of special interest is the growing frequency of obesity among young people, which increases the lifelong risk of chronic diseases. Research into this problem could help find the most optimal methods of controlling obesity to reduce the resources spent to treat its complications. This review explores the impact of obesity on various aspects of human life. The literature search included the resources published in 2028-2013 and indexed in PubMed and eLibrary.


  • Open Access

    Features of type 2 diabetes mellitus and its pharmacotherapy in outpatients

    by I G Samoilova, D V Podchinenova, M V Matveeva, O A Oleynik, A E Stankova, D A Kudlay, A А Mazurina, I D Pak, M I Kharakhulah

    Background. Type 2 diabetes mellitus (DM) remains the most common type of DM and is associat-ed with disabling complications, reduced quality of life and reduced life expectancy. Satisfactory control of carbohydrate metabolism remains the key way to manage them. Aim. To perform a retrospective analysis of carbohydrate metabolism (in terms of glycated hemoglobin – HbA1c), the prevalence of complications, and features of hypoglycemic and concomitant therapy in patients with type 2 DM. Materials and methods. The analysis of sex and age characteristics, achieved level of HbA1c, diabetes complications, sugar-reducing and concomitant therapy according to the data of outpatient records of the patients who are on dispensary registration with an endocrinologist in the Endocrinology Department of the Consultative and Diagnostic Polyclinic of the Tomsk Regional Clinical Hospital in Tomsk was carried out. Results. 546 outpatient medical records of patients with type 2 DM were analysed, among which there were 39.6% men (n=216) with a history of type 2 DM 8.0 years [3.0; 13.0] , median age 64.0 years [54.5; 71.0] and 60.4% women (n=330), history of type 2 DM 10.0 years [5.0; 15.0], median age 70.0 years [63.0; 75.0]. The achieved HbA1c level in men was 7.6% [6.3; 9.0] and in women 7.4% [6.4; 9.1]. 19.4% of men and 13.6% of women had an aggravated history of type 2 DM. According to the history, 6.5% of men (n=14) and 3% of women (n=10) with type 2 DM had a history of stroke, and myocardial infarction 12% (n=26) and 1.5% (n=5), respectively. Among the analysed outpatient records of type 2 DM patients, 18.5% of men (n=40) and 12.4% of women (n=41) were found to have diabetic nephropathy. Diabetic retinopathy was reported in 9.3% (n=20) of men and 4.2% (n=14) of women. Diabetic macroangiopathies were detected in 29.6% (n=64) of males and 9.7% (n=32) of females. Among other chronic complications of DM, diabetic neuroosteoarthropathy was recorded in 1% (n=2) of males and 3% (n=10) of females, diabetic polyneuropathy in 25% (n=54) and 21.5% (n=71), respectively. Diabetic foot was diagnosed in 1.9% (n=4) of men and 1.8% (n=6) of women. Among comorbid pathology, obesity was diagnosed in 45.4% (n=88) of men and 69.1% (n=228) of women, dyslipidaemia in 10.2% (n=22) and 10.6% (n=35) respectively, hypertension in 39.8% (n=86) and 32.6% (n=108) of cases. The diagnosis of non-alcoholic fatty liver disease was verified in 3.7% of men (n=7) and 1.8% of women (n=6), chronic heart failure in 7.4% of men (n=16) and 2.4% of women (n=8) registered for type 2 DM. According to the analysed outpatient records, 4.1% (n=23) of patients received diet therapy, 48.3% (n=263) received monotherapy and 47.6% (n=260) received combination therapy for type 2 DM. Metformin was the most commonly used monotherapy for type 2 DM 36.1% (n=197), followed by insulin 6.9% (n=38), sulfonylurea derivatives – 2.7% (n=15). Combination of metformin and dipeptidyl peptidase-4 inhibitors (13.9%) was the most commonly used combination therapy. Conclusion. Analysis of the current situation in the diabetology service will help to identify weaknesses and strengths, which is necessary to optimise existing therapeutic approaches in accordance with current clinical recommendations.


  • Autoimmune polyendocrine syndrome type 1 in an 11-year- old boy

    by Yu. G. Samoilova, M. V. Matveeva, O. A. Oleynik, D. A. Kudlay, D. V. Podchinenova, T. D. Vachadze, E. V. Gorbatenko, Ю. Г. Самойлова

    Autoimmune polyendocrine syndrome type 1 is a rare autosomal recessive hereditary pathology — a defect in the autoimmune regulator gene (AIRE), which develops with endocrine and non-endocrine manifestations in childhood. The disease is characterized by clinical polymorphism, which makes timely diagnosis difficult. The article describes a clinical case of an 11-year-old patient with autoimmune polyendocrine syndrome type 1, in whom the course of the disease was erased for a long period. The high quality of life of such patients is possible with timely, individually selected substitution therapy, followed by dispensary observation.